Illumina Grail

Illumina may buy back Grail

U.S. should have enough COVID-19 vaccine by Q3 2021, CDC head tells Senate panel


AstraZeneca resumes COVID-19 vaccine trial


Pfizer touts animal trial results for COVID-19 vaccine candidate

COVID-19 coronavirus

Drug companies agree not to release COVID-19 vaccine until it’s ready

LabCorp launches flu-COVID diagnostic combo

Navitor Pharmaceuticals age gracefully

How Navitor could improve the way you age gracefully

Nestlé to acquire peanut allergy drugmaker for $2.6B


AstraZeneca denies it’s seeking an EUA for its COVID-19 vaccine candidate